USPTO serial 87364631
GENCLONE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 31, 2017
- Examiner
- GAGLIARDI, JEANINE
- Law office
- TMO LAW OFFICE 120
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with GENCLONE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Genesee Scientific Corporation
San Diego, CA, US
Genesee Scientific Corporation
San Diego, CA, US
El Cajon, CA, US
Genesee Scientific Corporation
San Diego, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anita B. Polott
Anita B. Polott Morgan, Lewis & Bockius LLP1111 Pennsylvania Avenue, NWAttn: TMSUWashington, DC 20004Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemicals, chemicals, and chemical products for laboratory research, scientific research, medical research, biological processing other than for medical or veterinary purposes, and the manufacture of pharmaceuticals, namely, buffers for cell cultures, cell growth media, cell growth sera, proteins, amino acids, and cell culture media components in the nature of amino acids, cell growth sera, chemical additives, and biochemical additives; nutritional media for maintenance and growth of cells in culture for scientific and research use, namely, classical cell culture media, cell growth media, cell culture reagents, buffers for cell cultures, and distilled water; deionised water for laboratory, scientific and medical research; cell culture reagents for scientific research, medical research, and the manufacture of pharmaceuticals; eukaryotic cell growth media and sera for scientific and research use | ACTIVE | Jan 2, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genesee Scientific Corporation
- Other trademarks owned by Genesee Scientific Corporation
- Other trademarks owned by GENESEE SCIENTIFIC LLC
- Other trademarks owned by Genesee Scientific Corporation
- Other trademarks in Class 001
- Similar marks named GENCLONE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 1, 2026 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jan 12, 2024 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jan 12, 2024 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Jan 12, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 30, 2023 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Oct 31, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 27, 2021 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 31, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 15, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 15, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 26, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 15, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 15, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 15, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 15, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 15, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 8, 2017 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 8, 2017 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 8, 2017 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 1, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 15, 2017 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Mar 14, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 13, 2017 | NWAP | NEW APPLICATION ENTERED | — |